Additional file 2: of Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Autor: Minniti, Giuseppe, Anzellini, Dimitri, Reverberi, Chiara, Cappellini, Gian, Marchetti, Luca, Bianciardi, Federico, Bozzao, Alessandro, Osti, Mattia, Gentile, Pier, Esposito, Vincenzo
Rok vydání: 2019
Předmět:
DOI: 10.6084/m9.figshare.7986047
Popis: Figure S2. Kaplan-Meier analysis of intracranial progression-free survival (PFS) and overall survival (OS) in patients who received dexamethasone (yes, blue line) or not (not, red line) during treatments. For PFS, 6-month and 12-month rates were 42.3 and 24.2%, and 73.6 and 35.9% respectively, in patients receiving dexamethasone or not. For OS, respective rates were 91.2 and 57.3% and 96 and 76.1%. (PDF 40 kb)
Databáze: OpenAIRE